We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

99 hedge funds and large institutions have $851M invested in Heron Therapeutics in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $14.2M | Put options by funds: $8.7M

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

0% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 36

7% less funds holding

Funds holding: 107 → 99 (-8)

30% less capital invested

Capital invested by funds: $1.21B → $851M (-$363M)

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

Holders
99
Holders Change
-8
Holders Change %
-7.48%
% of All Funds
2.64%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
13
Increased
36
Reduced
36
Closed
21
Calls
$14.2M
Puts
$8.7M
Net Calls
+$5.54M
Net Calls Change
-$25.7M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$32.6M
2
VMI
VHCP Management II
New York
+$8.01M
3
JHIU
Janus Henderson Investors US
Colorado
+$7.23M
4
PHS
PFM Health Sciences
California
+$5.84M
5
PAM
Panagora Asset Management
Massachusetts
+$2.3M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$15.1M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$11.6M
3
KCM
Kingdon Capital Management
New York
-$8.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$5.94M
5
State Street
State Street
Massachusetts
-$4.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
LOAMU
101
Lombard Odier Asset Management (USA)
New York
– -$2.46M -91,938 Closed
OAM
102
Oxford Asset Management
United Kingdom
– -$2.21M -80,036 Closed
FO
103
FT Options
Illinois
– -$1.4M -71,049 Closed
MCM
104
Moore Capital Management
New York
– -$1.74M -65,000 Closed
PPA
105
Parametric Portfolio Associates
Washington
– -$1.33M -49,894 Closed
NC
106
Nexthera Capital
New York
– -$630K -23,600 Closed
CI
107
Cowen Inc
New York
– -$481K -18,000 Closed
DC
108
Deere & Company
Illinois
– -$479K -17,926 Closed
SO
109
STRS Ohio
Ohio
– -$239K -12,100 Closed
PP
110
Paloma Partners
Connecticut
– -$316K -11,845 Closed
TI
111
Trexquant Investment
Connecticut
– -$296K -11,072 Closed
FPC
112
Falcon Point Capital
California
– -$291K -10,897 Closed
QSS
113
Quantitative Systematic Strategies
Florida
– -$303K -10,854 Closed
BNP Paribas Financial Markets
114
BNP Paribas Financial Markets
France
– -$189K -7,076 Closed
FAM
115
Formidable Asset Management
Ohio
– -$19K -700 Closed
QT
116
Quantbot Technologies
New York
– -$4K -170 Closed
Royal Bank of Canada
117
Royal Bank of Canada
Ontario, Canada
– -$3.12K -158 -91%
DADC
118
D.A. Davidson & Co
Montana
– -$2K -100 Closed
1 2 3 4
5

HRTX Hedge Fund Activity: Q1 2016 in Review

99 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2016, worth a combined $851M — down 30% from $1.21B a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of HRTX and 13 opened new positions — a net loss of 8 holders — while 36 trimmed existing stakes and 36 added.

The largest buyer was Franklin Resources, adding an estimated $32.6M. The largest seller was Broadfin Capital, cutting an estimated $15.1M.

  • 99 institutional investors held Heron Therapeutics (HRTX) as of Q1 2016, down from 107 in Q4 2015.
  • Funds reported $851M of Heron Therapeutics stock for Q1 2016, down 30% quarter-over-quarter.
  • 13 funds opened new Heron Therapeutics positions in Q1 2016 and 21 closed out, a net change of -8 holders.
  • The largest Heron Therapeutics buyer in Q1 2016 was Franklin Resources, an estimated $32.6M added.
  • The largest Heron Therapeutics seller in Q1 2016 was Broadfin Capital, an estimated $15.1M sold.

Based on aggregated 13F filings for Q1 2016.